MSF TB Treatment in Mumbai, India
We fill gaps in India’s health system and provide medical care to people who would otherwise struggle to access it.

We have a number of long-standing projects in India, which we run in conjunction with the state authorities to address existing healthcare needs and emerging public health concerns.

We also run mobile clinics in remote areas of the country, where even preventable, treatable conditions such as malaria can assume life-threatening proportions.

Key Activities

Kala azar-HIV co-infection in Bihar, Animated explainer | ENG

Explaining kala azar-HIV co-infection

Have you heard of kala azar?

Kala azar is a neglected but potentially fatal tropical disease. India accounts for 30 per cent of cases worldwide.

This short animation explains what kala azar is, how it relates to HIV, and what we are doing in response.

Since 80 per cent of India's kala azar cases are reported in Bihar, we set up a programme there in 2007.

People living with HIV are particularly vulnerable to kala azar, so since 2016 we have been focusing on treating patients co-infected with the two diseases, in partnership with the Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Bihar.

Journal article

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India

2 Jan 2014
Journal article

Must address worrying stock out of tuberculosis drugs

Press Release 17 Jun 2013
Activists from across Europe stage flashmob in front of the European Parliament
Project Update

EU-India free trade deal puts millions of lives at risk

Press Release 9 Apr 2013

Indian supreme court delivers verdict in Novartis case

Press Release 1 Apr 2013
FTA Protest Delhi - February 2012

Under pressure from Europe to sign off on trade deal that will harm access to medicines

Project Update 13 Mar 2013

Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug

Statement 18 Jan 2013

Double frontal attack on the 'pharmacy of the developing world'

Voices from the Field 17 Sep 2012

Novartis challenges pro-health patent law

Press Release 11 Sep 2012

Bayer attempting to block affordable patented drugs

Press Release 3 Sep 2012

Patients struggle to find MDR-TB treatment

Project Update 12 Jul 2012

About the Novartis Drop the Case campaign

Project Update 15 Feb 2012

MSF launches new Novartis campaign

Project Update 15 Feb 2012

Contact us

Treating kala azar-HIV co-infection in Bihar, India
MSF India

AISF Building, 1st & 2nd Floor
Amar Colony, Lajpat Nagar -IV